Skip to content

Lucira Health, Inc.

Delisted

CIK 1652724fmd_0E2M4RK0RJVWK1H7VEN6TP7S68Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2020 to Sep 30, 2022, 11 periods

Latest annual · FY2021

Millions
Total revenues
93
Gross profit
10
Operating income
(65)
Net income
(65)
Free cash flow
(116)

Latest quarter · Q3 FY2022

Millions
Total revenues
34
Gross profit
(100)
Operating income
(126)
Net income
(127)
Free cash flow
(35)
Open Financials

Lucira Health, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$93.1 million$269,000+34,492.9%10-K 2022-03-31 · proof
Gross profit$10.2 million-$1.7 million10-K 2022-03-31 · proof
Operating income-$65.1 million-$31.9 million10-K 2022-03-31 · proof
Net income-$64.8 million-$37.3 million10-K 2022-03-31 · proof
Cash from operating activities-$100.9 million-$32.5 million10-K 2022-03-31 · proof
Free cash flow-$116.3 million-$51.3 million10-K 2022-03-31 · proof
Total assets$240.4 million$92.7 million+159.3%10-K 2022-03-31 · proof
Total liabilities$51.6 million$33.9 million+51.9%10-K 2022-03-31 · proof
Cash and cash equivalents$106 million$58.2 million+82.1%10-K 2022-03-31 · proof
What was Lucira Health, Inc.'s revenue in fiscal 2021?
Lucira Health, Inc. reported revenue of $93.1 million for fiscal 2021 (the year ended Dec 31, 2021), against $269,000 the year before (+34,492.9%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What was Lucira Health, Inc.'s gross profit in fiscal 2021?
Lucira Health, Inc. reported gross profit of $10.2 million for fiscal 2021 (the year ended Dec 31, 2021), against -$1.7 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What was Lucira Health, Inc.'s operating income in fiscal 2021?
Lucira Health, Inc. reported operating income of -$65.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$31.9 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What was Lucira Health, Inc.'s net income in fiscal 2021?
Lucira Health, Inc. reported net income of -$64.8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$37.3 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What was Lucira Health, Inc.'s cash from operating activities in fiscal 2021?
Lucira Health, Inc. reported cash from operating activities of -$100.9 million for fiscal 2021 (the year ended Dec 31, 2021), against -$32.5 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What was Lucira Health, Inc.'s free cash flow in fiscal 2021?
Lucira Health, Inc. reported free cash flow of -$116.3 million for fiscal 2021 (the year ended Dec 31, 2021), against -$51.3 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What are Lucira Health, Inc.'s total assets?
As of Dec 31, 2021, Lucira Health, Inc. reported total assets of $240.4 million, against $92.7 million a year earlier (+159.3%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What are Lucira Health, Inc.'s total liabilities?
As of Dec 31, 2021, Lucira Health, Inc. reported total liabilities of $51.6 million, against $33.9 million a year earlier (+51.9%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What are Lucira Health, Inc.'s cash and cash equivalents?
As of Dec 31, 2021, Lucira Health, Inc. reported cash and cash equivalents of $106 million, against $58.2 million a year earlier (+82.1%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1652724&period_type=annual&limit=5"

Information only, not investment advice.